NLS Pharmaceutics AG (NLSP)
NASDAQ: NLSP
· Real-Time Price · USD
2.54
-0.07 (-2.68%)
At close: Aug 15, 2025, 2:15 PM
NLS Pharmaceutics Fail-to-Deliver
Total FTD Shares
7.36K
Below Average
FTD / Avg. Volume
2.19%
Low Impact
1-Year Change
-88.8%
Negative Trend
FTD Chart
As of Jul 14, 2025,
NLS Pharmaceutics AG has
7,364
shares failed to deliver, representing 2.19%
of the average daily volume of
335,837
shares. Over the past year, the monthly average FTD is
58,608
shares, with the current level 87% below
the historical average, indicating
low
settlement pressure. The weighted FTD ratio above 1% suggests potential liquidity constraints or heightened short-selling activity.
FTD History
| Date | Price | FTD Shares | % Change |
|---|---|---|---|
| Jul 14, 2025 | 2.13 | 7.36K | +40.56% |
| Jun 30, 2025 | 2.9 | 5.24K | -43.51% |
| May 29, 2025 | 2.34 | 9.27K | +310.72% |
| Apr 30, 2025 | 1.47 | 2.26K | +799.60% |
| Mar 28, 2025 | 1.3 | 251 | -89.66% |
| Feb 28, 2025 | 1.84 | 2.43K | -62.02% |
| Jan 30, 2025 | 1.98 | 6.39K | -94.07% |
| Dec 31, 2024 | 2.11 | 107.74K | +108.77% |
| Nov 29, 2024 | 3.38 | 51.61K | +12100.47% |
| Oct 30, 2024 | 3.86 | 423 | -96.96% |
| Sep 30, 2024 | 5.07 | 13.91K | -74.57% |
| Aug 28, 2024 | 6.28 | 54.7K | -88.72% |
| Jul 31, 2024 | 8.78 | 484.96K | -85.24% |
| Jun 28, 2024 | 8.68 | 3.29M | +14307.40% |
| May 30, 2024 | 6.65 | 22.81K | +2443.26% |
| Apr 23, 2024 | 5.21 | 897 | -96.32% |
| Mar 22, 2024 | 7.2 | 24.4K | +470.49% |
| Feb 29, 2024 | 15.47 | 4.28K | +2732.45% |
| Jan 31, 2024 | 18.4 | 151 | +2416.67% |
| Dec 29, 2023 | 23.6 | 6 | -99.32% |
| Nov 24, 2023 | 16.01 | 880 | +153.60% |
| Oct 25, 2023 | 20.8 | 347 | +110.30% |
| Sep 29, 2023 | 28 | 165 | +38.66% |
| Aug 14, 2023 | 32.84 | 119 | -98.76% |
| Jul 31, 2023 | 37.11 | 9.63K | +22821.43% |
| Jun 28, 2023 | 38.76 | 42 | -89.90% |
| May 19, 2023 | 45.6 | 416 | -88.48% |
| Apr 26, 2023 | 58.2 | 3.61K | +2115.34% |
| Mar 30, 2023 | 59.6 | 163 | -72.28% |
| Feb 28, 2023 | 57.2 | 588 | +37.06% |
| Jan 17, 2023 | 58 | 429 | n/a |